Cronos (CRON) Cash & Equivalents (2016 - 2026)
Cronos' (CRON) quarterly Cash & Equivalents came in at $821.9 million in Q1 2026, up 3.01% year-on-year from $797.8 million in Q1 2025, and up 3.8% quarter-over-quarter from $791.8 million in Q4 2025.
Cronos (CRON) Cash & Equivalents (2016 - 2026) Analysis & Trends
Cronos' Cash & Equivalents history runs 11 years deep, the most recent figure standing at $821.9 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 3.01% year-over-year to $821.9 million in Q1 2026; TTM through Mar 2026 was $821.9 million, a 3.01% increase from a year earlier, with the FY2025 full-year figure at $791.8 million, down 7.8% from the prior year.
- Cash & Equivalents advanced to $821.9 million in Q1 2026 per CRON's latest filing, from $791.8 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $862.0 million in Q3 2024 and bottomed at $409.4 million in Q2 2023.
- The 5-year median for Cash & Equivalents is $791.8 million (2025), against an average of $736.9 million.
- Across the five-year window, Cash & Equivalents slumped 51.98% in 2023 and jumped 107.16% in 2024, its largest moves.
- Year by year, Cash & Equivalents stood at $764.6 million in 2022, then fell by 12.47% to $669.3 million in 2023, then advanced by 28.32% to $858.8 million in 2024, then decreased by 7.8% to $791.8 million in 2025, then grew by 3.8% to $821.9 million in 2026.
- Per Business Quant, the three latest CRON Cash & Equivalents figures stand at $821.9 million (Q1 2026), $791.8 million (Q4 2025), and $784.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.28 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 821.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 821.86 Mn |
| Dec 31, 2025 | 791.79 Mn |
| Sep 30, 2025 | 784.17 Mn |
| Jun 30, 2025 | 794.42 Mn |
| Mar 31, 2025 | 797.82 Mn |
| Dec 31, 2024 | 858.81 Mn |
| Sep 30, 2024 | 862.03 Mn |
| Jun 30, 2024 | 848.19 Mn |
| Mar 31, 2024 | 855.11 Mn |
| Dec 31, 2023 | 669.29 Mn |
| Sep 30, 2023 | 571.66 Mn |
| Jun 30, 2023 | 409.43 Mn |
| Mar 31, 2023 | 413.67 Mn |
| Dec 31, 2022 | 764.64 Mn |
| Sep 30, 2022 | 633.30 Mn |
| Jun 30, 2022 | 789.54 Mn |
| Mar 31, 2022 | 861.54 Mn |
| Dec 31, 2021 | 886.97 Mn |
| Sep 30, 2021 | 842.57 Mn |
| Jun 30, 2021 | 895.18 Mn |